La Jolla Pharmaceutical
Last update: 17 days ago
Pharmaceuticals
United States (USA)
Its 10 main executivesRecent executive movements at La Jolla Pharmaceutical
George Tidmarsh, Director, President, Chief Executive Officer and Secretary, has left the company (news posted on November 25 2019).
Create an alert
to follow the executive moves at La Jolla Pharmaceutical.
Latest M&A news in Pharmaceuticals.
Novartis has announced the acquisition of Medicines (posted on Nov 27, 2019).
Glaukos has acquired Avedro (posted on Nov 22, 2019).
Bristol-Myers Squibb has acquired Celgene (posted on Nov 21, 2019).
La Jolla Pharmaceutical is one of the...
Most searched biographies at La Jolla Pharmaceutical
Click on an executive to view his biography >
Other contacts in the Pharmaceuticals industry
Latest news about La Jolla Pharmaceutical
La Jolla Pharmaceutical Company Announces Management Transition | La Jolla Pharmaceutical Company
La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results | La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2019 and Highlights Recent Corporate Progress | La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company Announces Positive Results from Pre-Specified Interim Analysis of Phase 2 Study of LJPC-401 in Patients with Hereditary Hemochromatosis | La Jolla Pharmaceutical Company
La Jolla Pharmaceutical Company Announces U.S. FDA’s Grant of Breakthrough Therapy Designation for LJPC-0118 for the Treatment of Severe Malaria | La Jolla Pharmaceutical Company
La Jolla Pharmaceutical on Wikipedia, Google News & Yahoo Finance
La Jolla Pharmaceutical on LinkedIn, Twitter & YouTube
La Jolla Pharmaceutical has 1,959 competitors including Johnson & Johnson (United States (USA)), Roche (Switzerland) and Pfizer (United States (USA)).
Contact by email its executives including Kevin Tang 
Call La Jolla Pharmaceutical at +1 858....
